Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 192.60 2.53
Larsen & 1524.40 7.32
Sslt 291.60 0.45
Bharti A 373.00 5.26
Tata Stl 544.90 0.48
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Bliss GVS Pharma Limited
Bliss GVS Pharma Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:506197NSE:BLISSGVSBloomberg:BLIS@INReuters:BLIS.BO
Market Lot: 1Face Value: 1ISIN Demat: INE416D01022
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
08-OCT-13 The Food and Drugs Authority (FDA) with immediate effect banned the importation and distribution of all medicinal products manufactured by Bliss GVS Pharma, India into Ghana. 03-OCT-13 Bliss GVS Pharma clarified on news, that Pfizer is taking with the management to acquire stake in the company. 16-JAN-12 Credit rating agency, ICRA has assigned a long-term rating of BBB+ to the Rs 60 million enhanced fund based limits of Bliss GVS P...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
FDA blacklists Bliss GVS Pharma from importing fake malaria medicines in Ghana  -IRIS 08-Oct-13
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2009(9)31-Mar-2009(12)31-Mar-2008 (12)
Net sales 1245.861329.551034.31
Other Income11.3069.221.18
Total Income1257.161398.771035.49
Cost of goods sold817.06937.71608.55
OPBDIT440.10461.06426.94
PAT350.66367.21332.52
Gross Block---
Equity capital103.15103.1564.47
EPS (Rs.)--0.00
DPS (Rs.)---
BV (Rs.)---
P/E range (x)--NA
Debt / Equity (x)---
Operating margin (% of OI)35.033.041.2
Net margin (% of OI)27.926.332.1
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
6/29A , Udit Mittal Industrial Society
Andheri-Kurla Road
Andheri (East)
Mumbai
Maharashtra-400 059
PHONE
(022) 2850 5387/ 3870
FAX
(022) 2856 3930
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer